ALX Oncology Holdings Inc. - Common Stock — Liquidità (NASDAQ:ALXO) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -38.29 M-68.1 M-89.22 M-130.36 M-121.91 M-84.14 M -78.13 M Flussi di cassa derivanti dalle attività di investimento 610 K-4.92 M-235.42 M44.66 M86.26 M82.59 M -50.09 M Liquidità derivante dalle attività di finanziamento 462.88 M2.47 M9.86 M59.29 M30.82 M362 K 139.89 M Liquidità libera -38.29 M-68.1 M-89.22 M-130.36 M-121.91 M-84.35 M -78.33 M

Notizie

Relazione sugli utili: ALX Oncology supera le previsioni del Q1 2026

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

ALX Oncology Holdings Inc. (ALXO) Q1 2026 Earnings Call Transcript

ALX Oncology Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ALXO) 2026-05-08

ALX Oncology Q1 2026: risposta al 100% valida la strategia CD47

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

ALX Oncology nomina Jeff Knight Chief Development Officer

Wells Fargo avvia copertura su ALX Oncology con rating overweight

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

IBRX Stock Jumps on Progress in NK Cell Therapy Production

JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study